Please login to the form below

Not currently logged in
Email:
Password:

Zealand Pharma appoints new CEO

Britt Meelby Jensen joins from cancer diagnostics firm Dako

Denmark-based Zealand Pharma has appointed Britt Meelby Jensen as its new CEO, effective from January 15, 2015.

Jensen is currently CEO at Dako, which specialises in cancer diagnostics and is part of Agilent Technologies.

Prior to this, she held numerous senior roles at Novo Nordisk over eleven years including international marketing director and VP global marketing, working her way up to corporate VP of global marketing, market access and commercial excellence.

Jensen succeeds David Solomon, who has held the position of CEO at Zealand for six years.

Regarding his departure from the company, Solomon said: "Zealand is entering a new phase in its development, where the company will focus more on late-stage development and pre-commercialisation of proprietary pipeline products. This requires a CEO with a different profile and experience.

“I am glad to have contributed to the growth and maturity of Zealand's business and look forward to new challenges. I am certain that Britt Meelby Jensen will contribute her significant marketing and operational experience to Zealand's continued development."
Solomon will remain in the position until the handover date to ensure a smooth transition.

Daniël Jan Ellens, chairman of Zealand's board of directors, added: "We are thankful for the tremendous work David has put into Zealand in the past six years and the results achieved.

“Under his leadership, the company was taken public, and his experience and visionary capacity have built the business and the pipeline including innovative partnerships and brought the company to its current position, representing a strong basis for further growth."

11th November 2014

From: Research, Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
GCI Health

GCI Health London is a young, vibrant powerhouse in the European industry with a mission to redefine healthcare communications, starting...

Latest intelligence

The relevance of patient perspectives to value
Exploring the evolution of patient involvement in health technology assessment, and the role of the patient voice in market access....
How is the NHS Long-term Plan being put into action?
Steve How, Paul Midgley and Oli Hudson, of Wilmington Healthcare, explore some of the changes that have occurred since the plan was published...
real world studies
The evolution of real-world studies
How industry and regulators are using real-world data...

Infographics